{"id":351347,"date":"2026-11-18T09:40:26","date_gmt":"2026-11-18T04:10:26","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=351347"},"modified":"2026-11-18T09:40:26","modified_gmt":"2026-11-18T04:10:26","slug":"archean-chemical-analyst-review","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/","title":{"rendered":"Archean Chemical Analyst Review 2027: Bromine Revenue Up 76%, ICICI Securities Trims Target to \u20b9620"},"content":{"rendered":"<div style=\"background:#E8F1FF;border-left:5px solid #1565C0;padding:16px 20px;margin:0 0 20px 0;border-radius:6px;\">\n<p><strong>Archean Chemical Industries Stock Snapshot (17 Nov 2026 close)<\/strong><\/p>\n<ul>\n<li><strong>Current Market Price (CMP):<\/strong> \u20b9439.50<\/li>\n<li><strong>52-Week High \/ Low:<\/strong> \u20b9639.80 \/ \u20b9413.80<\/li>\n<li><strong>Market Capitalisation:<\/strong> \u20b95,425 crore<\/li>\n<li><strong>P\/E Ratio vs Industry P\/E:<\/strong> 55.4 vs 33.3<\/li>\n<li><strong>Latest Quarter (Q2 FY27) Revenue:<\/strong> \u20b9301.61 crore<\/li>\n<li><strong>Latest Quarter (Q2 FY27) Net Profit:<\/strong> \u20b931.33 crore<\/li>\n<\/ul>\n<\/div>\n<div style=\"background:#F0F9FF;border-left:5px solid #2E7D32;padding:16px 20px;margin:0 0 20px 0;\">\n<p><strong>Quick Answer:<\/strong> The <strong>Archean Chemical analyst review 2027<\/strong> centres on a bromine recovery. ICICI Securities kept a Buy rating after Q2 FY27 but cut its target to \u20b9620 from \u20b9655 in November 2026, about 41% above the 17 November close of \u20b9439.50. Q2 FY27 consolidated income rose about 26% to \u20b9301.61 crore as bromine revenue jumped 76%, but industrial salt volumes fell and profit rose only about 8% to \u20b931.33 crore. The stock is about 31% below its 52-week high, so the <strong>Archean Chemical share price target 2027<\/strong> depends on bromine output and salt shipments recovering together.<\/p>\n<\/div>\n<p>The <strong>Archean Chemical analyst review 2027<\/strong> covers India&#8217;s largest exporter of bromine and industrial salt, which runs marine chemical operations on the Gujarat coast. Readers searching for an <strong>Archean Chemical share price target 2027<\/strong> will find a named Buy call with a large gap to the market price, after a year in which profit fell sharply.<\/p>\n<p><a href=\"https:\/\/univest.in\/stocks\/aci\/archean-chemical-industries-ltd-share-price-today\">Archean Chemical Industries<\/a> closed at \u20b9439.50 on 17 November 2026, about 31% below its 52-week high of \u20b9639.80 and just 6% above its low of \u20b9413.80. This Archean Chemical analyst review 2027 covers the <strong>brokerage<\/strong> view, the September quarter, new businesses and the <strong>Archean Chemical stock outlook 2027<\/strong>.<\/p>\n<p><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=archean-chemical-analyst-review\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/#What_Brokerages_Say_in_the_Archean_Chemical_Analyst_Review_2027\" title=\"What Brokerages Say in the Archean Chemical Analyst Review 2027\">What Brokerages Say in the Archean Chemical Analyst Review 2027<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/#Q2_FY27_Results_in_the_Archean_Chemical_Analyst_Review_2027\" title=\"Q2 FY27 Results in the Archean Chemical Analyst Review 2027\">Q2 FY27 Results in the Archean Chemical Analyst Review 2027<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/#How_Archean_Chemical_Makes_Money\" title=\"How Archean Chemical Makes Money\">How Archean Chemical Makes Money<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/#Growth_Triggers_in_the_Archean_Chemical_Analyst_Review_2027\" title=\"Growth Triggers in the Archean Chemical Analyst Review 2027\">Growth Triggers in the Archean Chemical Analyst Review 2027<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/#Key_Risks_in_the_Archean_Chemical_Analyst_Review_2027\" title=\"Key Risks in the Archean Chemical Analyst Review 2027\">Key Risks in the Archean Chemical Analyst Review 2027<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/#Archean_Chemical_Analyst_Review_2027_Stock_at_a_Glance\" title=\"Archean Chemical Analyst Review 2027: Stock at a Glance\">Archean Chemical Analyst Review 2027: Stock at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/#Shareholding_Trend\" title=\"Shareholding Trend\">Shareholding Trend<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/#What_to_Watch_After_the_Archean_Chemical_Analyst_Review_2027\" title=\"What to Watch After the Archean Chemical Analyst Review 2027\">What to Watch After the Archean Chemical Analyst Review 2027<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/#Final_Word_on_the_Archean_Chemical_Analyst_Review_2027\" title=\"Final Word on the Archean Chemical Analyst Review 2027\">Final Word on the Archean Chemical Analyst Review 2027<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/#What_does_the_Archean_Chemical_analyst_review_2027_show\" title=\"What does the Archean Chemical analyst review 2027 show?\">What does the Archean Chemical analyst review 2027 show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/#What_is_the_Archean_Chemical_share_price_target_2027_from_brokerages\" title=\"What is the Archean Chemical share price target 2027 from brokerages?\">What is the Archean Chemical share price target 2027 from brokerages?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/#Why_did_profit_rise_only_8_when_income_rose_26\" title=\"Why did profit rise only 8% when income rose 26%?\">Why did profit rise only 8% when income rose 26%?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/#How_does_Archean_Chemical_make_money\" title=\"How does Archean Chemical make money?\">How does Archean Chemical make money?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/#Is_Archean_Chemical_expensive_based_on_the_Archean_Chemical_analyst_review_2027\" title=\"Is Archean Chemical expensive, based on the Archean Chemical analyst review 2027?\">Is Archean Chemical expensive, based on the Archean Chemical analyst review 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/#What_risks_does_the_Archean_Chemical_analyst_review_2027_highlight\" title=\"What risks does the Archean Chemical analyst review 2027 highlight?\">What risks does the Archean Chemical analyst review 2027 highlight?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/archean-chemical-analyst-review\/#What_should_investors_track_after_the_Archean_Chemical_analyst_review_2027\" title=\"What should investors track after the Archean Chemical analyst review 2027?\">What should investors track after the Archean Chemical analyst review 2027?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Brokerages_Say_in_the_Archean_Chemical_Analyst_Review_2027\"><\/span><strong>What Brokerages Say in the Archean Chemical Analyst Review 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Brokerage<\/th>\n<th>Rating<\/th>\n<th>Target Price<\/th>\n<th>Date<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>ICICI Securities<\/td>\n<td>Buy<\/td>\n<td>\u20b9620 (cut from \u20b9655)<\/td>\n<td>November 2026<\/td>\n<\/tr>\n<tr>\n<td>ICICI Securities<\/td>\n<td>Buy<\/td>\n<td>\u20b9655 (raised from \u20b9640)<\/td>\n<td>September 2026<\/td>\n<\/tr>\n<tr>\n<td>ICICI Securities<\/td>\n<td>Buy<\/td>\n<td>\u20b9640<\/td>\n<td>August 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>ICICI Securities has kept a Buy rating through FY27. In September 2026 it named Archean its top specialty chemicals pick and raised the target to \u20b9655, expecting earnings to recover sharply from the second half of FY27. It estimated bromine revenue growth of about 37% a year and bromine <strong>EBITDA<\/strong> growth of about 42.5% a year as production and prices normalise after three weak years.<\/p>\n<p>After <strong>Q2 FY27<\/strong>, the <strong>brokerage<\/strong> cut its target to \u20b9620, using an unchanged 16 times FY28 estimated <strong>EBITDA<\/strong>. That target is about 41% above the current price. The trim shows that near-term numbers came in softer than hoped, even as the long-term view held.<\/p>\n<p>In the Archean Chemical analyst review 2027, ICICI Securities also highlights the planned silicon carbide power semiconductor business as part of the long-term case. That project is early, so most of the near-term target rests on bromine.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Q2_FY27_Results_in_the_Archean_Chemical_Analyst_Review_2027\"><\/span><strong>Q2 FY27 Results in the Archean Chemical Analyst Review 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Quarter<\/th>\n<th>Total Income<\/th>\n<th>EBITDA<\/th>\n<th>Net Profit<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Sep 2026 (Q2 FY27)<\/td>\n<td>\u20b9301.61 crore<\/td>\n<td>\u20b974.46 crore<\/td>\n<td>\u20b931.33 crore<\/td>\n<\/tr>\n<tr>\n<td>Jun 2026 (Q1 FY27)<\/td>\n<td>\u20b9332.81 crore<\/td>\n<td>\u20b972.87 crore<\/td>\n<td>\u20b930.35 crore<\/td>\n<\/tr>\n<tr>\n<td>Mar 2026 (Q4 FY26)<\/td>\n<td>\u20b9306.33 crore<\/td>\n<td>\u20b949.08 crore<\/td>\n<td>\u20b912.23 crore<\/td>\n<\/tr>\n<tr>\n<td>Dec 2025 (Q3 FY26)<\/td>\n<td>\u20b9261.51 crore<\/td>\n<td>\u20b961.35 crore<\/td>\n<td>\u20b924.00 crore<\/td>\n<\/tr>\n<tr>\n<td>Sep 2025 (Q2 FY26)<\/td>\n<td>\u20b9239.56 crore<\/td>\n<td>\u20b968.98 crore<\/td>\n<td>\u20b929.04 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Consolidated income rose about 25.9% to \u20b9301.61 crore, led by bromine. Bromine and derivatives revenue jumped 76% to about \u20b9127.5 crore on volumes up 29% to about 4,100 tonnes. Consolidated <strong>EBITDA<\/strong> grew only about 7.9%, and net profit rose about 8% to \u20b931.33 crore.<\/p>\n<p>The gap came from industrial salt, where some shipments were deferred because of softer PVC and caustic soda markets. H1 FY27 consolidated <strong>EBITDA<\/strong> fell about 5.1% to \u20b9147.3 crore. For the Archean Chemical analyst review 2027, bromine is clearly recovering, but salt held back profit.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_Archean_Chemical_Makes_Money\"><\/span><strong>How Archean Chemical Makes Money<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Bromine:<\/strong> extracted from sea brine at Hajipir in Gujarat and sold to pharma, agrochemical, flame retardant and oil field customers.<\/li>\n<li><strong>Industrial salt:<\/strong> exported in bulk, mainly to chemical makers abroad who use it for chlor-alkali production.<\/li>\n<li><strong>Sulphate of potash:<\/strong> a specialty fertiliser made from the same brine.<\/li>\n<li><strong>New ventures:<\/strong> bromine derivatives through Acume Chemicals, specialty mud chemicals, silicon carbide power devices and zinc-bromide energy storage.<\/li>\n<\/ul>\n<p>Annual revenue fell to about \u20b91,108 crore in FY26 from \u20b91,373 crore in FY24, and profit fell to about \u20b9105 crore from \u20b9319 crore as bromine prices and output dropped. The Archean Chemical analyst review 2027 is essentially a bet on that trend reversing.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Growth_Triggers_in_the_Archean_Chemical_Analyst_Review_2027\"><\/span><strong>Growth Triggers in the Archean Chemical Analyst Review 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Bromine recovery:<\/strong> revenue up 76% and volume up 29% in <strong>Q2 FY27<\/strong>.<\/li>\n<li><strong>Production guidance:<\/strong> the company guided to exit FY27 at 20,000 to 25,000 tonnes of annualised bromine output at a blended price near \u20b9300 per kg.<\/li>\n<li><strong>Derivatives break-even:<\/strong> Acume Chemicals, the bromine derivatives unit, has reached <strong>EBITDA<\/strong> break-even.<\/li>\n<li><strong>Semiconductor option:<\/strong> the silicon carbide power device venture is a long-term growth path.<\/li>\n<li><strong>Low gearing:<\/strong> <strong>debt to equity<\/strong> of about 0.28 limits balance sheet strain, a support in the Archean Chemical analyst review 2027.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_in_the_Archean_Chemical_Analyst_Review_2027\"><\/span><strong>Key Risks in the Archean Chemical Analyst Review 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Salt weakness:<\/strong> deferred shipments cut Q2 profit and could recur if PVC and caustic soda demand stays soft.<\/li>\n<li><strong>Bromine prices:<\/strong> any fall in global bromine prices would hit margins directly.<\/li>\n<li><strong>Weather and brine:<\/strong> monsoon dilution can reduce bromine output in some quarters.<\/li>\n<li><strong>Valuation:<\/strong> a <strong>P\/E<\/strong> near 55 is high because trailing profit is depressed.<\/li>\n<li><strong>New venture risk:<\/strong> semiconductor and energy storage projects need capital and time.<\/li>\n<li><strong>Domestic selling:<\/strong> domestic institutions cut their stake to 21.33% from 25.52%.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/univest.in\/screeners\">Compare Archean Chemical With Specialty Chemical Stocks on the Univest Screener<\/a><\/strong><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Archean_Chemical_Analyst_Review_2027_Stock_at_a_Glance\"><\/span><strong>Archean Chemical Analyst Review 2027: Stock at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th>Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Share Price (17 Nov 2026 close)<\/td>\n<td>\u20b9439.50<\/td>\n<\/tr>\n<tr>\n<td>52-Week High \/ Low<\/td>\n<td>\u20b9639.80 \/ \u20b9413.80<\/td>\n<\/tr>\n<tr>\n<td>Market Capitalisation<\/td>\n<td>\u20b95,425 crore<\/td>\n<\/tr>\n<tr>\n<td>P\/E (TTM) vs Industry<\/td>\n<td>55.4 vs 33.3<\/td>\n<\/tr>\n<tr>\n<td>Price to Book<\/td>\n<td>2.76<\/td>\n<\/tr>\n<tr>\n<td>Book Value per Share<\/td>\n<td>\u20b9159.02<\/td>\n<\/tr>\n<tr>\n<td>Return on Equity<\/td>\n<td>5.08%<\/td>\n<\/tr>\n<tr>\n<td>Debt to Equity<\/td>\n<td>0.28<\/td>\n<\/tr>\n<tr>\n<td>Dividend Yield<\/td>\n<td>0.57%<\/td>\n<\/tr>\n<tr>\n<td>FY26 Revenue \/ Net Profit<\/td>\n<td>\u20b91,108.0 crore \/ \u20b9105.4 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The high <strong>P\/E<\/strong> reflects a cyclical low in earnings rather than a premium valuation, and price to <strong>book value<\/strong> is a moderate 2.8. Return on equity of about 5% is far below the levels seen in FY24. The Archean Chemical analyst review 2027 hinges on whether profit returns towards those earlier levels.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Shareholding_Trend\"><\/span><strong>Shareholding Trend<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Holder<\/th>\n<th>Sep 2025<\/th>\n<th>Sep 2026<\/th>\n<th>Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Promoters<\/td>\n<td>53.44%<\/td>\n<td>53.43%<\/td>\n<td>-0.01 pts<\/td>\n<\/tr>\n<tr>\n<td>Foreign Investors (FII)<\/td>\n<td>11.15%<\/td>\n<td>10.41%<\/td>\n<td>-0.74 pts<\/td>\n<\/tr>\n<tr>\n<td>Domestic Institutions (DII)<\/td>\n<td>25.52%<\/td>\n<td>21.33%<\/td>\n<td>-4.19 pts<\/td>\n<\/tr>\n<tr>\n<td>Public<\/td>\n<td>9.89%<\/td>\n<td>14.83%<\/td>\n<td>+4.94 pts<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The <strong>promoter<\/strong> group, Chemikas Speciality LLP at 30.53% and Pendurthi Ranjit at 22.90%, holds a steady 53.43%. Domestic institutions sold about four percentage points, and retail investors bought. That shift added to price pressure during the Archean Chemical analyst review 2027 period.<\/p>\n<p><strong><a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a><\/strong><\/p>\n<p><strong><a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a><\/strong><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_to_Watch_After_the_Archean_Chemical_Analyst_Review_2027\"><\/span><strong>What to Watch After the Archean Chemical Analyst Review 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Bromine run rate:<\/strong> progress towards 20,000 to 25,000 tonnes of annualised output.<\/li>\n<li><strong>Salt shipments:<\/strong> whether deferred cargoes are shipped in Q3 FY27.<\/li>\n<li><strong>Bromine prices:<\/strong> how close realisations stay to \u20b9300 per kg.<\/li>\n<li><strong>New ventures:<\/strong> milestones in silicon carbide devices and energy storage.<\/li>\n<li><strong>Target revisions:<\/strong> any change to ICICI Securities&#8217; \u20b9620 would reset the Archean Chemical share price target 2027.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Final_Word_on_the_Archean_Chemical_Analyst_Review_2027\"><\/span><strong>Final Word on the Archean Chemical Analyst Review 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>Archean Chemical analyst review 2027<\/strong> shows a bromine business that is clearly recovering, with revenue up 76% in <strong>Q2 FY27<\/strong>, held back by weak salt shipments. ICICI Securities keeps a Buy call at \u20b9620, about 41% above the price, but trimmed its target after the quarter.<\/p>\n<p>The <strong>Archean Chemical stock outlook 2027<\/strong> depends on bromine output reaching guidance, salt volumes recovering and new ventures progressing. Univest does not give a buy or sell call.<\/p>\n<div style=\"background:#FFF5F5;border-left:5px solid #C62828;padding:14px 18px;margin:24px 0;\">\n<p style=\"color:#C62828;\"><strong>Disclaimer:<\/strong> This article is for educational and informational purposes only and is not investment advice or a recommendation to buy, sell or hold any security. Brokerage ratings and target prices quoted here are opinions of third-party research houses; Univest does not endorse them and gives no buy or sell call. Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div class=\"faq-schema\">\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_Archean_Chemical_analyst_review_2027_show\"><\/span><strong>What does the Archean Chemical analyst review 2027 show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>It shows a bromine-led recovery with a positive brokerage view. Q2 FY27 income rose about 25.9% to \u20b9301.61 crore as bromine revenue jumped 76%. ICICI Securities keeps a Buy rating with a \u20b9620 target.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Archean_Chemical_share_price_target_2027_from_brokerages\"><\/span><strong>What is the Archean Chemical share price target 2027 from brokerages?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>ICICI Securities has a Buy rating with a \u20b9620 target, cut from \u20b9655 after Q2 FY27 in November 2026. It is based on 16 times FY28 estimated EBITDA. The stock closed at \u20b9439.50 on 17 November 2026, about 41% below that target.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_profit_rise_only_8_when_income_rose_26\"><\/span><strong>Why did profit rise only 8% when income rose 26%?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Industrial salt volumes fell as some shipments were deferred because of weak PVC and caustic soda markets. Consolidated EBITDA rose only about 7.9%. Net profit was \u20b931.33 crore against \u20b929.04 crore a year earlier.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Archean_Chemical_make_money\"><\/span><strong>How does Archean Chemical make money?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>It extracts bromine and industrial salt from sea brine in Gujarat and also makes sulphate of potash. Bromine goes to pharma, agrochemical and flame retardant buyers, while salt is mainly exported. FY26 revenue was about \u20b91,108 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Archean_Chemical_expensive_based_on_the_Archean_Chemical_analyst_review_2027\"><\/span><strong>Is Archean Chemical expensive, based on the Archean Chemical analyst review 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The P\/E of about 55.4 looks high because trailing profit is at a cyclical low. Price to book is about 2.8. Return on equity is about 5%, well below earlier years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_does_the_Archean_Chemical_analyst_review_2027_highlight\"><\/span><strong>What risks does the Archean Chemical analyst review 2027 highlight?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The main risks are weak salt shipments, bromine price swings and weather affecting brine output. Domestic institutions cut their stake to 21.33% from 25.52%. New ventures in semiconductors and storage need capital.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_track_after_the_Archean_Chemical_analyst_review_2027\"><\/span><strong>What should investors track after the Archean Chemical analyst review 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Track bromine output against the 20,000 to 25,000 tonne exit guidance and realisations near \u20b9300 per kg. Watch whether deferred salt shipments move in Q3 FY27. Any change to the \u20b9620 target will also matter.<\/p>\n<\/div>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What does the Archean Chemical analyst review 2027 show?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It shows a bromine-led recovery with a positive brokerage view. Q2 FY27 income rose about 25.9% to \u20b9301.61 crore as bromine revenue jumped 76%. ICICI Securities keeps a Buy rating with a \u20b9620 target.\"}},{\"@type\":\"Question\",\"name\":\"What is the Archean Chemical share price target 2027 from brokerages?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"ICICI Securities has a Buy rating with a \u20b9620 target, cut from \u20b9655 after Q2 FY27 in November 2026. It is based on 16 times FY28 estimated EBITDA. The stock closed at \u20b9439.50 on 17 November 2026, about 41% below that target.\"}},{\"@type\":\"Question\",\"name\":\"Why did profit rise only 8% when income rose 26%?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Industrial salt volumes fell as some shipments were deferred because of weak PVC and caustic soda markets. Consolidated EBITDA rose only about 7.9%. Net profit was \u20b931.33 crore against \u20b929.04 crore a year earlier.\"}},{\"@type\":\"Question\",\"name\":\"How does Archean Chemical make money?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It extracts bromine and industrial salt from sea brine in Gujarat and also makes sulphate of potash. Bromine goes to pharma, agrochemical and flame retardant buyers, while salt is mainly exported. FY26 revenue was about \u20b91,108 crore.\"}},{\"@type\":\"Question\",\"name\":\"Is Archean Chemical expensive, based on the Archean Chemical analyst review 2027?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The P\/E of about 55.4 looks high because trailing profit is at a cyclical low. Price to book is about 2.8. Return on equity is about 5%, well below earlier years.\"}},{\"@type\":\"Question\",\"name\":\"What risks does the Archean Chemical analyst review 2027 highlight?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are weak salt shipments, bromine price swings and weather affecting brine output. Domestic institutions cut their stake to 21.33% from 25.52%. New ventures in semiconductors and storage need capital.\"}},{\"@type\":\"Question\",\"name\":\"What should investors track after the Archean Chemical analyst review 2027?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Track bromine output against the 20,000 to 25,000 tonne exit guidance and realisations near \u20b9300 per kg. Watch whether deferred salt shipments move in Q3 FY27. Any change to the \u20b9620 target will also matter.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Archean Chemical Industries grew Q2 FY27 income about 26% on a 76% jump in bromine revenue, while ICICI Securities kept a Buy rating but cut its target to \u20b9620. We review the call, results, new ventures, valuation and risks for 2027.<\/p>\n","protected":false},"author":38,"featured_media":351345,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[24444,4341,25421,25422],"class_list":["post-351347","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-24444","tag-analyst-review","tag-archean-chemical-industries","tag-specialty-marine-chemicals"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["351345"],"rank_math_title":["Archean Chemical Share Price Target 2027: Broker View"],"rank_math_description":["Archean Chemical analyst review 2027: ICICI Securities Buy at \u20b9620, bromine revenue up 76% in Q2 FY27, salt weakness and the share price target 2027 outlook."],"rank_math_focus_keyword":["Archean Chemical analyst review 2027"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/archean-chemical-analyst-review-2027-bromine-revenue-up-76-icici-securities.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/351347","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=351347"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/351347\/revisions"}],"predecessor-version":[{"id":351348,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/351347\/revisions\/351348"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/351345"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=351347"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=351347"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=351347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}